to achieve better treatments, such as low drug utilization in vivo, toxic and side effects, as well as frequent medications to maintain drug efficacy in vivo. [7] Nowadays, the pharmaceutical research has gradually shifted to the development and exploration of new drug release systems as traditional pharmaceutical administration such as injections, tablets, capsules, patches, and aerosols can no longer meet the needs of clinical use. Drug release system refers to the combination of actives and biological carrier materials, which allows drugs to be released to target tissues after oral/injection by functionalizing the surface of the microparticles with molecules or antibodies, and it has facilitated the diagnosis and therapy of cancer. [8,9] For example, developments in liposome-based drug delivery systems can provide reduced side effects, improved pharmacokinetics, and increased tumor uptake for pancreatic cancer therapy; [10] Progress in 5-Fluorouracil-loaded magnetic core-shell nanoparticles allows active therapy with digestive carcinoid; [11] Developments in folate-decorated maleilated pullulan-doxorubicin conjugate provides enhanced cellular uptake and higher cytotoxicity for stomach cancer therapy; [12] Advancement of lipidpolymer hybrid microsystem allows site-specific release of encapsulated drugs to treat breast cancer. [9] In general, the carrier materials of drug release system often employ synthetic or natural polymers which normally offer great biodegradability, stimuli-responsiveness for controlled release, and good biocompatibility. Typical examples include chitosan, collagen, polylactic acid (PLA), polyglycolic acid, lactic acid-glycolic acid copolymer, polycaprolactone (PCL), etc. [13][14][15][16] These carrier materials are continuously degrading after administration, and the controlled release of the drug can be achieved through diffusion, swelling, erosion, or biodegradation. Drugs or biological actives can be either physically or chemically encapsulated in such polymer materials to prepare microparticles with size at the micron scale (1 to 500 µm). [17][18][19] Currently, common methods used to fabricate drug-loaded microparticles mainly consist of solvent evaporation and spray drying. [20] These traditional methods rely on mechanical agitation or ultrasonic vibration to synthesize microparticles, which leads to drawbacks of high polydispersibility, low drug encapsulation, and uncontrollable drug release. [21] Droplet microfluidics offers precise and simultaneous control of multiple fluids at microscale, which enables synthesis of novel microparticles with compositional and structural diversity in a controllable way. The morphology and functionality of generated microparticles can be well designed by modulating the hydrodynamic profile as well as geometric structures. The synergistic combination of droplet microfluidics with biodegradable materials makes it possible to encapsulate actives/drugs inside microparticles at high efficiency for drug delivery. The utilization of these microfluidic-ge...